AI assistant
Glenmark Pharmaceuticals ltd — Call Transcript 2020
Oct 28, 2020
62608_rns_2020-10-28_cf836a0d-509d-4fae-8943-bda75fcdd90d.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [33 x 32] intentionally omitted <==
==> picture [148 x 45] intentionally omitted <==
October 28, 2020
To, To, Dy. General Manager The Manager – Listing, Department of Corporate Services, National Stock Exchange of India Ltd., BSE Ltd., Plot No. C/1, G Block, P. J. Towers, Dalal Street, Bandra Kurla Complex, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Ref: Scrip Code: 532296
Ref: Scrip Name: GLENMARK
Dear Sirs,
November 9, 2020 at 8:30 a.m. – 9:30 a.m. (IST) , for your information and record. Please note that the recording of the call will be available on our website within 24 hours of the call.
Thanking you.
Yours faithfully, For Glenmark Pharmaceuticals Ltd.
Digitally signed by HARISH HARISH VINAYAK KUBER VINAYAK KUBER Date: 2020.10.28 16:55:53 +05'30'
Harish Kuber
Company Secretary Compliance Officer
Tel: 4018 9999 / 4018 9879 Fax: 4018 9986 (Legal & Secretarial Dept.)
Encl: As above
Glenmark Pharmaceuticals Ltd. Glenmark House, B D Sawant Marg, Andheri (E), Mumbai 400 099 T: 91 22 4018 9999 F: 91 22 4018 9988 CIN No: L24299MH1977PLC019982 W: www.glenmarkpharma.com Registered office: B/2, Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai 400 026 E: [email protected]
==> picture [137 x 86] intentionally omitted <==
I N V I T A T I O N
Glenmark Q2 FY 2020 – 21 Results Earnings Call
Date: Monday, November 9, 2020 Time: 8:30 am – 9:30 am [IST]
Dial – in Numbers: Universal Access Number: +91 22 6280 1298 +91 22 7115 8199
USA: 1 866 746 2133 UK: 0 808 101 1573 Singapore: 800 101 2045 Hong Kong: 800 964 448
For any clarification, please contact:
Pragya Verma
E-mail: [email protected] Phone: +91 22 4018 9783
(Kindly note: Participant pin is not required)